Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • LifeCell ties-up with...

    LifeCell ties-up with Cryo-Save India for preserved umbilical cord stem cell samples

    Written by Ruby Khatun Khatun Published On 2017-10-11T09:58:54+05:30  |  Updated On 11 Oct 2017 9:58 AM IST
    LifeCell ties-up with Cryo-Save India for preserved umbilical cord stem cell samples

    Chennai: LifeCell announced the signing of a formal agreement with Cryo-Save India (Cryo-Save) for the formal transfer of all of its 18,000 cryopreserved umbilical cord units and corresponding customer agreements to LifeCell.


    The cryopreserved stem cells currently under the care of Cryo-Save would be transported to LifeCell’s preservation facility at Chennai. This transportation would occur in phases and is expected to take up to 3 months for completion.

    Further to the reassignment of the agreement to LifeCell, the customers of Cryo-Save will have opportunities to reap greater benefits of the decision to preserve their baby’s stem cells. Through LifeCell’s community stem cell banking program, these customers can now upgrade to receive unlimited access to a large, growing inventory of donor stem cells to get the complete protection of stem cells for the entire family. Furthermore, by upgrading to the Lifetime Storage Plan, the stem cell samples can be preserved for the entire lifetime of the baby.

    Speaking on the occasion Mayur Abhaya, MD, CEO, LifeCell said, “This transfer marks an important step to expand our business by leveraging our infrastructure and storage standards. It would also further strengthen our endeavor of becoming the country’s largest registry of cord blood stem cells. We are happy to welcome these 18,000 families into the ambit of our community and also extend benefits such as complete family protection and unlimited access to matching stem cells. We look forward to providing best in class service to the new members of the LifeCell family.”

    LifeCell's state-of-the-art storage facility in Chennai and Gurgaon currently houses more than 2,70,000 samples preserved umbilical cord blood and tissue stem cell units.


    Roderick M Stuart, MD, Cryo-Save India said, "We are happy to enter into this transaction with LifeCell - India's first and largest stem cell bank which provides highest quality services. LifeCell's state-of-the-art facility, laboratory standards, and excellent customer relations made a great match for us. We are happy that the families who had preserved with us would continue to be provided with same high-quality stem cell preservation service for years to come."


    Cryo-Save AG the brand and trademark owner has been storing umbilical cord stem cells for families all over the world since the year 2000. Cryo-Save India Pvt. Ltd. stored its first sample in India in the year 2008 at their processing and storage facility in Bangalore.

    agreementCryo-SaveCryo-Save India Pvt LtdHealthcareHealthcare NewsIndialaboratory standardsLifeCellMayur AbhayaRoderick M Stuartstem cellumbilical cord
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok